Literature DB >> 17391100

Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140.

Tomas Jakobsson1, Waffa Osman, Jan-Ake Gustafsson, Johanna Zilliacus, Anette Wärnmark.   

Abstract

Similarities in physiological roles of LXR (liver X receptors) and co-repressor RIP140 (receptor-interacting protein 140) in regulating energy homoeostasis and lipid and glucose metabolism suggest that the effects of LXR could at least partly be mediated by recruitment of the co-repressor RIP140. In the present study, we have elucidated the molecular basis for regulation of LXR transcriptional activity by RIP140. LXR is evenly localized in the nucleus and neither the N-terminal domain nor the LBD (ligand-binding domain) is necessary for nuclear localization. Both LXR subtypes, LXRalpha and LXRbeta, interact with RIP140 and co-localize in diffuse large nuclear domains. Interaction and co-localization are dependent on the LBD of the receptor. The C-terminal domain of RIP140 is sufficient for full repressive effect. None of the C-terminal NR (nuclear receptor)-boxes is required for the co-repressor activity, whereas the NR-box-like motif as well as additional elements in the C-terminal region are required for full repressive function. The C-terminal NR-box-like motif is necessary for interaction with LXRbeta, whereas additional elements are needed for strong interaction with LXRalpha. In conclusion, our results suggest that co-repression of LXR activity by RIP140 involves an atypical binding mode of RIP140 and a repression element in the RIP140 C-terminus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391100      PMCID: PMC1925237          DOI: 10.1042/BJ20070004

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Ligand-dependent formation of retinoid receptors, receptor-interacting protein 140 (RIP140), and histone deacetylase complex is mediated by a novel receptor-interacting motif of RIP140.

Authors:  L N Wei; M Farooqui; X Hu
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

Review 2.  The nuclear receptor superfamily.

Authors:  Marc Robinson-Rechavi; Hector Escriva Garcia; Vincent Laudet
Journal:  J Cell Sci       Date:  2003-02-15       Impact factor: 5.285

3.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003.

Authors:  Brigitte Boeckmann; Amos Bairoch; Rolf Apweiler; Marie-Claude Blatter; Anne Estreicher; Elisabeth Gasteiger; Maria J Martin; Karine Michoud; Claire O'Donovan; Isabelle Phan; Sandrine Pilbout; Michel Schneider
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

4.  Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue.

Authors:  Thomas M Stulnig; Knut R Steffensen; Hui Gao; Mark Reimers; Karin Dahlman-Wright; Gertrud U Schuster; Jan-Ake Gustafsson
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

5.  Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.

Authors:  J Zilliacus; E Holter; H Wakui; H Tazawa; E Treuter; J A Gustafsson
Journal:  Mol Endocrinol       Date:  2001-04

6.  Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha.

Authors:  Knut Tomas Dalen; Stine Marie Ulven; Krister Bamberg; Jan-Ake Gustafsson; Hilde I Nebb
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

7.  Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140.

Authors:  Hiroshi Tazawa; Waffa Osman; Yutaka Shoji; Eckardt Treuter; Jan-Ake Gustafsson; Johanna Zilliacus
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.

Authors:  Bryan A Laffitte; Lily C Chao; Jing Li; Robert Walczak; Sarah Hummasti; Sean B Joseph; Antonio Castrillo; Damien C Wilpitz; David J Mangelsdorf; Jon L Collins; Enrique Saez; Peter Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

9.  Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.

Authors:  Guoqing Cao; Yu Liang; Carol L Broderick; Brian A Oldham; Thomas P Beyer; Robert J Schmidt; Youyan Zhang; Keith R Stayrook; Chen Suen; Keith A Otto; Anne R Miller; Jiannong Dai; Patricia Foxworthy; Hong Gao; Timothy P Ryan; Xian-Cheng Jiang; Thomas P Burris; Patrick I Eacho; Garret J Etgen
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

10.  On the role of liver X receptors in lipid accumulation in adipocytes.

Authors:  Lene K Juvet; Sissel M Andresen; Gertrud U Schuster; Knut Tomas Dalen; Kari Anne R Tobin; Kristin Hollung; Fred Haugen; Severina Jacinto; Stine M Ulven; Krister Bamberg; Jan-Ake Gustafsson; Hilde I Nebb
Journal:  Mol Endocrinol       Date:  2003-02
View more
  8 in total

1.  RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages.

Authors:  Yi-Wei Lin; Pu-Ste Liu; Neeta Adhikari; Jennifer L Hall; Li-Na Wei
Journal:  J Mol Cell Cardiol       Date:  2014-12-18       Impact factor: 5.000

2.  Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II.

Authors:  Mengyang Liu; Yuanli Chen; Ling Zhang; Qixue Wang; Xingzhe Ma; Xiaoju Li; Rong Xiang; Yan Zhu; Shucun Qin; Yang Yu; Xian-cheng Jiang; Yajun Duan; Jihong Han
Journal:  J Biol Chem       Date:  2015-04-25       Impact factor: 5.157

3.  Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis.

Authors:  Balachandar Nedumaran; Gwang Sik Kim; Sungpyo Hong; Young-Sil Yoon; Yong-Hoon Kim; Chul-Ho Lee; Young Chul Lee; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

4.  KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting.

Authors:  Yoshinori Takeuchi; Naoya Yahagi; Yuichi Aita; Yuki Murayama; Yoshikazu Sawada; Xiaoying Piao; Naoki Toya; Yukari Oya; Akito Shikama; Ayako Takarada; Yukari Masuda; Makiko Nishi; Midori Kubota; Yoshihiko Izumida; Takashi Yamamoto; Motohiro Sekiya; Takashi Matsuzaka; Yoshimi Nakagawa; Osamu Urayama; Yasushi Kawakami; Yoko Iizuka; Takanari Gotoda; Keiji Itaka; Kazunori Kataoka; Ryozo Nagai; Takashi Kadowaki; Nobuhiro Yamada; Yuan Lu; Mukesh K Jain; Hitoshi Shimano
Journal:  Cell Rep       Date:  2016-08-18       Impact factor: 9.423

Review 5.  Liver X receptors and fat cell metabolism.

Authors:  J Laurencikiene; M Rydén
Journal:  Int J Obes (Lond)       Date:  2012-02-28       Impact factor: 5.095

6.  Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy.

Authors:  P Saliba-Gustafsson; M Pedrelli; K Gertow; O Werngren; V Janas; S Pourteymour; D Baldassarre; E Tremoli; F Veglia; R Rauramaa; A J Smit; P Giral; S Kurl; M Pirro; U de Faire; S E Humphries; A Hamsten; I Gonçalves; M Orho-Melander; A Franco-Cereceda; J Borén; P Eriksson; J Magné; P Parini; E Ehrenborg
Journal:  J Intern Med       Date:  2019-07-29       Impact factor: 8.989

7.  Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors.

Authors:  M Futter; H Diekmann; E Schoenmakers; O Sadiq; K Chatterjee; D C Rubinsztein
Journal:  J Med Genet       Date:  2009-05-17       Impact factor: 6.318

8.  The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor.

Authors:  Birger Herzog; Magnus Hallberg; Asha Seth; Angela Woods; Roger White; Malcolm G Parker
Journal:  Mol Endocrinol       Date:  2007-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.